このページの翻訳は実験的なもので、現在開発中です。お待ちしております
Abbott Laboratories マネジメント
マネジメント 基準チェック /34
Abbott Laboratories'の CEO はRobert Fordで、 Oct2018年に任命され、 の在任期間は 5.83年です。 の年間総報酬は$ 23.27Mで、 6.4%給与と93.6%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の0.024%を直接所有しており、その価値は$ 46.33M 。経営陣と取締役会の平均在任期間はそれぞれ5.6年と5.5年です。
主要情報
Robert Ford
最高経営責任者
US$23.3m
報酬総額
| CEO給与比率 | 6.4% |
| CEO在任期間 | 5.9yrs |
| CEOの所有権 | 0.02% |
| 経営陣の平均在職期間 | 5.7yrs |
| 取締役会の平均在任期間 | 5.6yrs |
経営陣の近況
Recent updates
Abbott Laboratories: Cardiovascular Disease Has Been A Tailwind, But Things Could Change
Sep 11A Look At The Intrinsic Value Of Abbott Laboratories (NYSE:ABT)
Aug 16
Abbott Laboratories: Driving Value By Scaling Innovations
Aug 13Abbott Laboratories: A Strong Healthcare Stock For Long-Term Dividend Growth Investors
Aug 05Abbott Laboratories: When Double-Digit Device Growth Apparently Isn't Enough
Jul 13These 4 Measures Indicate That Abbott Laboratories (NYSE:ABT) Is Using Debt Reasonably Well
Jul 01Abbott Laboratories (NYSE:ABT) Is Doing The Right Things To Multiply Its Share Price
Jun 18Investors Still Waiting For A Pull Back In Abbott Laboratories (NYSE:ABT)
Jun 04Abbott Laboratories: Why I Agree With Wall Street On This One
Jun 04Abbott Laboratories: Buying More Of This Top-Notch Dividend Growth Stock
May 18Abbott Laboratories: Organic Growth Will Be Key To Q1 Earnings
Apr 17Estimating The Intrinsic Value Of Abbott Laboratories (NYSE:ABT)
Apr 15Abbott Laboratories: Buy This World-Class Dividend Growth Stock Now
Mar 21Abbott Laboratories (NYSE:ABT) Might Have The Makings Of A Multi-Bagger
Mar 19Here's Why Abbott Laboratories (NYSE:ABT) Can Manage Its Debt Responsibly
Mar 06Abbott Labs' Reversal Is Here - CGM Tailwinds In 2024
Feb 27Abbott Laboratories' (NYSE:ABT) Shares May Have Run Too Fast Too Soon
Feb 08The King Is Back: Abbott Laboratories' Path To >11% Annual Returns
Jan 29The Abbott Laboratories (NYSE:ABT) Full-Year Results Are Out And Analysts Have Published New Forecasts
Jan 26Abbott Laboratories: Another Healthy Dividend Hike From This Dividend King
Dec 28Estimating The Intrinsic Value Of Abbott Laboratories (NYSE:ABT)
Dec 27Abbott Laboratories: A 'Must-Have' In A Defensive Dividend Growth Portfolio
Dec 03Is Abbott Laboratories (NYSE:ABT) Using Too Much Debt?
Nov 29Abbott Laboratories: One Of The Safest Dividend Growth Stocks On The Market
Nov 26Abbott Labs Vs. Thermo Fisher: Which Is The Better Healthcare Stock?
Nov 01CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | US$6b |
| Mar 31 2024 | n/a | n/a | US$6b |
| Dec 31 2023 | US$23m | US$2m | US$6b |
| Sep 30 2023 | n/a | n/a | US$5b |
| Jun 30 2023 | n/a | n/a | US$5b |
| Mar 31 2023 | n/a | n/a | US$6b |
| Dec 31 2022 | US$22m | US$2m | US$7b |
| Sep 30 2022 | n/a | n/a | US$8b |
| Jun 30 2022 | n/a | n/a | US$9b |
| Mar 31 2022 | n/a | n/a | US$8b |
| Dec 31 2021 | US$25m | US$1m | US$7b |
| Sep 30 2021 | n/a | n/a | US$7b |
| Jun 30 2021 | n/a | n/a | US$6b |
| Mar 31 2021 | n/a | n/a | US$6b |
| Dec 31 2020 | US$20m | US$1m | US$4b |
| Sep 30 2020 | n/a | n/a | US$3b |
| Jun 30 2020 | n/a | n/a | US$3b |
| Mar 31 2020 | n/a | n/a | US$4b |
| Dec 31 2019 | US$12m | US$1m | US$4b |
| Sep 30 2019 | n/a | n/a | US$3b |
| Jun 30 2019 | n/a | n/a | US$3b |
| Mar 31 2019 | n/a | n/a | US$3b |
| Dec 31 2018 | US$8m | US$784k | US$2b |
| Sep 30 2018 | n/a | n/a | US$802m |
| Jun 30 2018 | n/a | n/a | US$812m |
| Mar 31 2018 | n/a | n/a | US$365m |
| Dec 31 2017 | US$5m | US$675k | US$344m |
報酬と市場: Robertの 総報酬 ($USD 23.27M ) は、 US市場 ($USD 13.21M ) の同規模の企業の平均を上回っています。
報酬と収益: Robertの報酬は、過去 1 年間の会社の業績と一致しています。
CEO（最高経営責任者
Robert Ford (50 yo)
5.9yrs
在職期間
US$23,268,171
報酬
Mr. Robert B. Ford has been the Chief Executive Officer of Abbott Laboratories since March 31, 2020 and also serves as its Chairman of the Board since December 10, 2021. He has been President at Abbott Lab...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Chairman of the Board | 5.9yrs | US$23.27m | 0.024% $ 47.5m | |
| CFO & Executive VP of Finance | less than a year | US$3.32m | 0.0023% $ 4.5m | |
| Executive VP | 11.7yrs | US$7.42m | 0.011% $ 21.0m | |
| Executive VP and Group President of Established Pharmaceuticals & Nutritional Products | 10yrs | US$5.93m | 0.0072% $ 14.3m | |
| Executive VP & Group President of Medical Devices | 5.7yrs | US$5.50m | 0.0035% $ 7.0m | |
| Senior VP of Business & Technology Services and Chief Information Officer | less than a year | データなし | データなし | |
| Vice President of Investor Relations. | no data | データなし | データなし | |
| VP and Chief Ethics & Compliance Officer | no data | データなし | データなし | |
| Vice President of Public Affairs & Corporate Marketing | no data | データなし | データなし | |
| Senior Vice President of Commercial Operations | 1.7yrs | データなし | データなし | |
| Executive Vice President of Human Resources | 5.1yrs | データなし | 0.0059% $ 11.7m | |
| Executive Vice President of Diabetes Care | 9.3yrs | データなし | 0.0041% $ 8.2m |
5.7yrs
平均在職期間
54yo
平均年齢
経験豊富な経営陣: ABTの経営陣は経験豊富で経験豊富です（平均在職期間は5.6年）。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Chairman of the Board | 4.8yrs | US$23.27m | 0.024% $ 47.5m | |
| Independent Director | 7.6yrs | US$349.29k | 0.39% $ 762.9m | |
| Independent Director | 7.7yrs | US$341.96k | 0.00020% $ 395.7k | |
| Lead Independent Director | 12.8yrs | US$405.96k | 0.00027% $ 534.1k | |
| Independent Director | 3.4yrs | US$337.96k | 0% $ 0 | |
| Independent Director | 15.9yrs | US$441.44k | 0% $ 0 | |
| Independent Director | 1.4yrs | US$283.96k | 0% $ 0 | |
| Independent Director | 6.3yrs | US$331.96k | 0.00018% $ 356.1k | |
| Independent Director | 12.8yrs | US$362.60k | 0.00015% $ 296.7k | |
| Independent Director | 2yrs | US$354.96k | 0% $ 0 | |
| Independent Director | 5yrs | US$331.19k | 0% $ 0 | |
| Independent Director | 3.1yrs | US$356.96k | 0% $ 0 |
5.6yrs
平均在職期間
62yo
平均年齢
経験豊富なボード: ABTの 取締役会 は 経験豊富 であると考えられます ( 5.4年の平均在任期間)。